• Assay Selection Tool

BellBrook Labs

  • Products
    • Transcreener® HTS Assay Kits
      • Transcreener® ADP² Kinase Assay Kits
        • Transcreener® ADP2 Assay Kit – FP Readout
        • Transcreener® ADP2 Assay Kit – FI Readout
        • Transcreener® ADP2 Assay Kit – TR-FRET Readout
      • Transcreener® ADO CD73 Assay Kit
      • Transcreener® ADPR Assay Kit
      • Transcreener® AMP²/GMP² Phosphodiesterase Assay Kits
        • Transcreener® AMP2/GMP2 FP Assay
        • Transcreener® AMP2/GMP2 Assay Kit – TR-FRET Readout
      • Transcreener® cGAMP cGAS Assay Kits
        • Transcreener® cGAMP Assay Kit – FP Readout
        • Transcreener® cGAMP Assay Kit – TR-FRET Readout
      • Transcreener dAMP Exonuclease Assay Kit
      • Transcreener® EPIGEN SAH Methyltransferase Assay Kit
      • Transcreener® GDP GTPase Assay Kits
        • Transcreener® GDP Assay Kit – FP Readout
        • Transcreener® GDP Assay Kit – FI Readout
        • Transcreener® GDP Assay Kit – TR-FRET Readout
      • Transcreener® UDP² Glycosyltransferase Assay Kits
        • Transcreener® UDP2 Assay Kit – FP Readout
        • Transcreener® UDP2 Assay Kit – FI Readout
        • Transcreener® UDP2 Assay Kit – TR-FRET Readout
      • Transcreener® 2-5A OAS Assay Kit
    • AptaFluor® HTS Assay Kits
      • AptaFluor® SAH Methyltransferase Assay Kit
    • Enzyme Assay Systems
      • CD38 Assay System
      • TREX1 Assay System
    • Recombinant Enzymes
      • Human CD38 Enzyme
      • Human cGAS Enzyme
      • Mouse cGAS Enzyme
      • Human DDX3 Enzyme
      • Human OAS1 Enzyme
      • Human TREX1 Enzyme
    • Assay Plates
    • Ordering Information
  • Services
    • Assay Development Services
    • Lead Discovery Services
    • GTPase Profiling Services
    • ATPase Profiling Services
  • Assays by Target
    • Kinase Assays
      • ADK Assays – Application
      • AMPK Assays – Application
      • IKK-beta Assays – Application
      • IRAK4 Assays – Application
      • JAK1 Assays – Application
      • JAK3 Assays – Application
      • MAPK8 Assays – Application
      • PKR Assays – Application
      • RIPK1 Assays – Application
      • RIPK2 Assays – Application
      • TBK1 Assays – Application
    • GTPase Assays
      • GAP Assays – Application
      • GEF Assays – Application
      • KRAS Assays – Application
      • HRAS Assays – Application
      • NRAS Assays – Application
      • RRAS Assays – Application
      • Rac1 Assays – Application
      • RhoA Assays – Application
      • RhoC Assays – Application
      • Cdc42 Assays – Application
      • Ran Assays – Application
    • Methyltransferase Assays
      • EZH2 Assays – Application
      • G9a Assays – Application
      • SET7/9 Assays – Application
      • SET8 Assays – Application
      • PRMT1 Assays – Application
      • PRMT3 Assays – Application
      • PRMT4 Assays – Application
    • STING Pathway Assays
      • cGAS Assay Kits
      • ENPP1 Assays – Application
      • TREX1 Assay System
      • IKK-beta Assays – Application
      • TBK1 Assays – Application
    • Nucleotidase Assays
      • CD38 Assay System
      • CD39 Assays – Application
      • CD73 Activity Assay Kits
    • Helicase / ATPase Assays
      • DDX3 Assays – Application
      • NSP13 Assays – Application
      • p97 Assays – Application
      • Ketohexokinase Assays – Application
    • Glycosyltransferase Assays
      • Toxin B Assays – Application
      • GALNT2 Assays – Application
      • GALNT3 Assays – Application
      • BGalT1 Assays – Application
    • Phosphodiesterase Assays
      • PDE3 Assays – Application
      • PDE4 Assays – Application
      • PDE5 Assays – Application
      • PDE7 Assays – Application
    • Ligase and Synthetase Assays
      • SUMO E1 Assays – Application
      • Acetyl CoA Synthetase Assays – Application
    • Exonuclease Assays
      • TREX1 Assay System
      • WRN Exonuclease Assays – Application
    • OAS Assays
      • OAS1 Assay Kits
    • Other Enzyme Assays
      • NUDT5 Assays – Application
  • Resources
    • Technical Manuals
    • Transcreener® Assays – Instrument Compatibility
    • Application Notes
    • Posters and Presentations
    • Publications
    • Transcreener® FAQ’s
    • Guides
      • Residence Time Guide
      • Hit Prioritization Guide
      • Kinases in Innate Immunity
  • Company
    • President’s Message
    • International Distributors
    • Careers
    • Downloads
    • Contact Us
  • Blog
  • MY CART
    No products in cart.

Transcreener ADP Assay Used to Discover RIPK1 Inhibitors

by Bellbrook Labs / Tuesday, 18 February 2020 / Published in Success Stories
RIPK1 Inhibitors Inflammatory disease treatment

Genentech discovers novel RIPK1 inhibitors – Like other serine/threonine protein kinases, receptor-interacting serine/threonine-protein kinase 1 (RIPK1) plays a role in several signaling pathways that keep us living healthy, functioning lives. RIPK1 is one of those enzymes’ that wears a variety of hats depending on what function needs attention. It contributes to cell death as well as cell survival using different cellar pathways. In regards to cell death, if RIPK1 is not operating correctly, inflammatory-related necroptosis is likely. The enzyme’s function in inflammatory regulation is critical for removing unwanted disease. While a failure in this regulation leads to unnecessary cell death contributing to inflammatory diseases such as psoriasis, ulcerative colitis, and rheumatoid arthritis.2

Significance of RIPK1 Inhibitors

Recent studies have shown that RIPK1 inhibitors have potential therapeutic effects particularly in diseases associated with atypical tumor necrosis factor receptor (TNFR) signaling.2 In necroptosis, it’s ultimately the complex of multiple proteins called the necrosome that recruits mixed kinase domain like protein (MLKL) allowing the cell membrane to rupture leading to death. RIPK1 has a hand in initiating this process. When TNF binds to its receptor, proteins including RIPK1 form TNFR-1 complex I.4 Eventually, the signaling pathway requires RIPK1 and RIPK3 to autophosphorylate each other; forming the necrosome.

Obviously, there are several proteins working together to achieve the goal of cell death; therefore,  numerous possible drug discoveries exist. A team of scientists found that specifically inactivating RIPK1 was superior to eliminating kidney ischemia–reperfusion injury, systemic inflammation compared to the loss of MLKL.3

It’s not only inflammatory disease, but other diseases such as Alzheimer’s disease (AD) could benefit from RIPK1 inhibitors. An overabundance of the protein has been found in patients with AD.4

Genentech’s Discovery

Genentech recently discovered bicyclic pyridone lactam compounds capable of treating inflammatory diseases.1 The scientists used the Transcreener® ADP² Kinase Assay to evaluate the different molecules and their ability to inhibit RIPK1. Making the assay unique, it detects the activity of most kinases including serine/threonine protein kinases; limiting the need for specific reagents and providing utilitarian potential. The capacity of RIPK1 to transfer a phosphate from ATP to another molecule (or substrate), forming ADP as a product was measured by using specific antibody labeled with a fluorophore; thus, showing inhibition in the case of Genentech’s discovery.

The discovery is exciting news for those suffering from inflammatory disease. And, like all discoveries, it expands on current knowledge in the field in order to enhance our understanding of disease and the signaling pathways involved.

References

  1. Patel, S., Genentech Inc, (2019). Bicyclic pyridone lactams and methods of use thereof. U.S. Patent Application 16/385,353. https://patents.google.com/patent/US20190241565A1/en
  2. Finger, J. N., Nino, J. B., Michael, C., Deutsch, J., Haag, H., Harris, P. A., … Gough, P. J. (2017). Identification of an antibody-based immunoassay for measuring direct target binding of RIPK1 inhibitors in cells and tissues, (October), 1–10. https://doi.org/10.1002/prp2.377
  3. Newton, K., Dugger, D. L., Maltzman, A., Greve, J. M., Hedehus, M., Carano, R. A. D., … Vucic, D. (2016). RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury, 1565–1576. https://doi.org/10.1038/cdd.2016.46
  4. Mason, A. R., Elia, L. P., & Finkbeiner, S. (2017). The receptor-interacting serine/threonine protein kinase 1 (RIPK1) regulates progranulin levels. Journal of Biological Chemistry, 292(8), 3262-3272. https://www.jbc.org/content/292/8/3262.short
Tagged under: kinase assay, RIPK1 Inhibitors, Transcreener ADP Kinase Assay

What you can read next

Lab IRAK4 Inhibitors Kinase Assay Kit
Uncovering IRAK4 Inhibitors with a Transcreener Kinase Assay Kit
Researchers Studying Hsp70 Activity
Researchers Validate Hsp70 Activity with the Transcreener ATPase Assay
Success Story: Development of a High Throughput Screening Assay to Identify Inhibitors of the de novo Purine Biosynthetic Pathway

Categories

  • Company
  • Emerging Targets
  • Epigenetics
  • HTS Assays
  • Innate Immunity
  • Neurodegenerative Diseases
  • News
  • Products
  • Resources
  • Success Stories
  • Uncategorized

Recent Posts

  • Preview of DNA Damage Repair Webinar

    [Webinar] Targeting DNA Damage Repair for Drug Discovery Using the Transcreener ADPR® Assay

    Interested in DNA damage repair pathways for dr...
  • Calculating MAPK14 Residence Time

    Transcreener® ADP2 Assay Delivers Precise Measurement of Functional MAPK14 Residence Time

    Researchers at the University of Tubingen use T...
  • DDX1 as a versatile RNA Helicase

    DDX1: A Versatile RNA Helicase

    DDX1 (Dead-Box Helicase 1) belongs to the DEAD-...
  • RAB2 Transports Membrane Bound Vesicles

    Investigating RAB2 as a Vesicle Transporter & Autophagy Initiator

    RAB2 is part of the RAB family of small GTPases...
  • PARP1 as a Hero vs Villain

    Is PARP1 a Hero or Villain?

    Not counting histones, PARP1 [Poly(ADP-ribose) ...

Archives

BellBrook Labs
1232 Fourier Drive, Suite 115
Madison, Wisconsin 53717 USA
(608) 443-2400

info@bellbrooklabs.com

 Copyright © 2023 BellBrook Labs | All Rights Reserved | Privacy Policy | Terms of Use | FCOI | Sitemap

TOP